Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label reveal trial
Journal of the American Academy of Dermatology | Feb 11, 2018
Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis
Journal of the European Academy of Dermatology and Venereology | Feb 11, 2018
Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the two phase 3, 29-day, randomized, controlled reveal trials
Journal of the American Academy of Dermatology | Feb 09, 2018
Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial
Journal of the American Academy of Dermatology | Feb 09, 2018